Fundraising FoxTriFlo Cardiovascular
Huntington Beach, US · Founded 2017 · Delaware corporation
Find your way into TriFlo Cardiovascular
Sign up to see every warm intro you have to TriFlo Cardiovascular
- Paths you didn't know you had: your email and LinkedIn already hold routes to the TriFlo Cardiovascular team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
LP
Luca PesceCEO
WD
William DangeloAsst. Secretary
Reported raises · per SEC filings
Form D private placements$14.7M disclosed across 3 rounds · 2017–2020
▶$13.8MraisedJun 2022 · 150 investors · OtherRule 506(b)
▶$13.8MraisedJun 2022 · 150 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Elton SatuskyExecutive Officer
- Christopher C. DeweyDirector
- Kunal SarkarDirector
- Aldo MaccariDirector
- Daniel Mahnert-LuegDirector
- Luca PesceExecutive Officer, Director
- Stephane PiatDirector
- John Paul UssiaDirector
- Offering amount
- $16.1M
- Amount sold
- $13.8M
- Sales commissions
- $480.2K
- Placement agents
- CEROS Financial Services, Inc.
- First sale
- Jun 2020
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$665KraisedJul 2019 · 13 investors · Other Health CareRule 506(b)
▶$665KraisedJul 2019 · 13 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Stephane PiatDirector
- Thierry ThaureExecutive Officer, Director
- Luca PesceExecutive Officer, Director
- Offering amount
- $665K
- Amount sold
- $665K
- First sale
- Oct 2018
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$300KraisedNov 2017 · 5 investors · BiotechnologyRule 506(b)
▶$300KraisedNov 2017 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- William DangeloExecutive Officer
- Luca PesceExecutive Officer
- Offering amount
- $300K
- Amount sold
- $300K
- Minimum investment
- $30K
- First sale
- Nov 2017
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has TriFlo Cardiovascular raised?
- TriFlo Cardiovascular has disclosed $14.7M raised across 3 rounds.
- Where is TriFlo Cardiovascular headquartered?
- TriFlo Cardiovascular is headquartered in Huntington Beach, US.